Paediatric prescribing: why children are not small adults.
作者信息
Ferro Albert
机构信息
Department of Clinical Pharmacology, Cardiovascular Division, British Heart Foundation Centre of Research Excellence, King's College London, London, SE1 9NH, United Kingdom.
出版信息
Br J Clin Pharmacol. 2015 Mar;79(3):351-3. doi: 10.1111/bcp.12540.
Abstract
摘要
相似文献
1
Paediatric prescribing: why children are not small adults.
Br J Clin Pharmacol. 2015 Mar;79(3):351-3. doi: 10.1111/bcp.12540.
2
Antibiotic prescribing is higher in deprived areas of England.
BMJ. 2015 Nov 12;351:h6117. doi: 10.1136/bmj.h6117.
3
Prescription of drugs contraindicated in children: a national community survey.
Eur J Clin Pharmacol. 2007 Jan;63(1):99-101. doi: 10.1007/s00228-006-0227-7. Epub 2006 Dec 5.
4
Melatonin: prescribing practices and adverse events.
Arch Dis Child. 2005 Nov;90(11):1206-7. doi: 10.1136/adc.2005.077289.
5
General Practice Research Database for prescribing analysis.
Lancet. 1998 Feb 7;351(9100):453-4. doi: 10.1016/S0140-6736(05)78411-7.
6
Hospital prescribing of antibiotics rose significantly between 2011 and 2014.
BMJ. 2015 Dec 11;351:h6753. doi: 10.1136/bmj.h6753.
7
Why are we still poisoning the elderly so often?
Can Fam Physician. 1993 Nov;39:2298-300, 2304-7.
8
Best practices: racial and ethnic effects on antipsychotic prescribing practices in a community mental health center.
Psychiatr Serv. 2003 Feb;54(2):177-9. doi: 10.1176/appi.ps.54.2.177.
9
Interpreting and analysing practice prescribing data.
Community Nurse. 2000 Jul;6(6):39-42.
10
Statin prescribing fell after drug became available over the counter.
BMJ. 2006 Sep 16;333(7568):569. doi: 10.1136/bmj.333.7568.569-c.
引用本文的文献
1
Global research landscape and burden of disease in pediatrics: Identifying the research gaps to set directions for a new general pediatric journal.
Pediatr Discov. 2023 Jun 10;1(1):e2. doi: 10.1002/pdi3.2. eCollection 2023 Jun.
2
A conceptual model of factors potentially influencing prescribing decisions for chronic conditions: an overview of systematic reviews.
BMC Med. 2025 Jul 1;23(1):364. doi: 10.1186/s12916-025-04194-9.
3
Paediatricians' knowledge, perceptions, preparedness and involvement towards paediatric antimicrobial stewardship in Pakistan: findings and the implications.
JAC Antimicrob Resist. 2024 Dec 9;6(6):dlae193. doi: 10.1093/jacamr/dlae193. eCollection 2024 Dec.
4
Will artificial intelligence widen the therapeutic gap between children and adults?
Pediatr Investig. 2023 Dec 1;8(1):1-6. doi: 10.1002/ped4.12407. eCollection 2024 Mar.
5
Prescribed medicine use and extent of off-label use according to age in a nationwide sample of Australian children.
Paediatr Perinat Epidemiol. 2022 Sep;36(5):726-737. doi: 10.1111/ppe.12870. Epub 2022 Feb 16.
6
A Proof of Concept of the Role of TDM-Based Clinical Pharmacological Advices in Optimizing Antimicrobial Therapy on Real-Time in Different Paediatric Settings.
Front Pharmacol. 2021 Sep 27;12:755075. doi: 10.3389/fphar.2021.755075. eCollection 2021.
7
Real-world Evidence for Adherence and Persistence with Atorvastatin Therapy.
Cardiol Ther. 2021 Dec;10(2):445-464. doi: 10.1007/s40119-021-00240-8. Epub 2021 Sep 29.
8
Efficacy and Safety of Etanercept Biosimilars Compared With the Originator for Treatment of Juvenile Arthritis: A Prospective Observational Study.
ACR Open Rheumatol. 2021 Nov;3(11):779-787. doi: 10.1002/acr2.11325. Epub 2021 Aug 27.
9
Mindfulness-Based Intervention Development for Children and Adolescents.
Mindfulness (N Y). 2020 Aug;11(8):1868-1883. doi: 10.1007/s12671-020-01360-3. Epub 2020 May 19.
10
No population left behind: Improving paediatric drug safety using informatics and systems biology.
Br J Clin Pharmacol. 2022 Feb;88(4):1464-1470. doi: 10.1111/bcp.14705. Epub 2021 Jan 19.
本文引用的文献
1
Pharmacogenomics--how close/far are we to practising individualized medicine for children?
Br J Clin Pharmacol. 2015 Mar;79(3):419-28. doi: 10.1111/bcp.12338.
2
Formulations for children: problems and solutions.
Br J Clin Pharmacol. 2015 Mar;79(3):405-18. doi: 10.1111/bcp.12268.
3
Paediatric pharmacokinetics: key considerations.
Br J Clin Pharmacol. 2015 Mar;79(3):395-404. doi: 10.1111/bcp.12267.
4
Comparative pharmacogenetic analysis of risk polymorphisms in Caucasian and Vietnamese children with acute lymphoblastic leukemia: prediction of therapeutic outcome?
Br J Clin Pharmacol. 2015 Mar;79(3):429-40. doi: 10.1111/bcp.12481.
5
Clinical trials of medicines in neonates: the influence of ethical and practical issues on design and conduct.
Br J Clin Pharmacol. 2015 Mar;79(3):370-8. doi: 10.1111/bcp.12467.
6
The development and assessment of biological treatments for children.
Br J Clin Pharmacol. 2015 Mar;79(3):379-94. doi: 10.1111/bcp.12406.
7
Improving antibiotic prescribing for children in the resource-poor setting.
Br J Clin Pharmacol. 2015 Mar;79(3):446-55. doi: 10.1111/bcp.12320.
8
Clinical trials in children.
Br J Clin Pharmacol. 2015 Mar;79(3):357-69. doi: 10.1111/bcp.12305.
9
The development of a national children's formulary.
Br J Clin Pharmacol. 2015 Mar;79(3):441-5. doi: 10.1111/bcp.12280.
Zotero 插件